Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Cryotherapy and Immunotherapy in Metastatic NSCLC
NCT06000358Recruiting
- Sponsor
- Lithuanian University of Health Sciences
- Start
- Apr 2023
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (4 arms), sponsored by Lithuanian University of Health Sciences. Primary endpoint: Changes in T Lymphocyte Count and Function in Response to Cryotherapy and Immunotherapy at 6 weeks. Started Apr 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06000358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06000358.